|
MDDR |
||
Most common reasons why people licensed MDDR:
|
MDDR is a database covering the patent literature, journals, meetings and congresses. Produced by Accelrys and Prous Science, the database contains over 180,000 biologically relevant compounds and well-defined derivatives, with updates adding about 10,000 a year to the database. The MDDR Finder allows you to search the database by structure or across relevant data fields. Accelrys also offers MDDR-3D. |
Focus: Drugs launched or under development, as referenced in the patent literature, conference proceedings, and other sources; descriptions of therapeutic action and biological activity; tracking of compounds through development phases Source: Formats: You can access MDDR also via a web service. |
FAQ concerning MDDR
Question
What is the meaning of the word "launched", "registered", etc. as concerns the MDDR database?
Answer
"Registered" means FDA approved. "Pre-registered" means NDA (New Drug Application) filed (or MAA, Marketing Authorization Application, or whatever the marketing approval request is called in a given country or territory).
These phases are also used in the MDL Drug Data Report:
-
Biological Testing (synthesis, some in vitro work)
-
Preclinical (in vivo work and/or lead compound designated for development)
-
IND (Investigational New Drug application filed - requesting permission to test in humans)
-
Clinical (in clinical trials, specific phase not known)
-
Phase I
-
Phase I/II
-
Phase II
-
Phase II/III
-
Phase III
-
Recommended Approval (approval recommended by FDA Advisory Committee)
-
Pre-registered (NDA or MAA filed)
-
Registered (marketing approval received from competent regulatory authority)
-
Launched (commercialized, on pharmacy shelves)
-
Phase IV
-
Not Determined
-
Discontinued (development for all indications discontinued)
-
Withdrawn (commercialized product withdrawn from market)
